Company profile: Synerlab
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing for medicinal products (human and veterinary), medical devices and food supplements, from product development to manufacturing and packaging across solid and semi-solid forms and non-sterile/sterile liquids. Services include formulation, galenics, analytics, clinical batches (phase 1–3), production of oral solids, non-sterile monodose, sterile multidose (nasal/eye/ear drops), and freeze drying, including biomolecular drugs.
Products and services
- Pharmaceutical Development: Architects clinical-phase drug development, including formulation, galenics, analytics, and clinical batch production from phase 1 to 3 for human and veterinary medicinal applications
- Contract Development and Manufacturing: Delivers industrial-scale end-to-end product development, manufacture, and packaging of medicinal human/veterinary products, medical devices, and food supplements across solid/semi-solid and non-sterile/sterile liquid dosage forms
- Sterile Multidose Production: Specializes in sterile-grade liquid multidose manufacturing of nasal sprays, eye drops, and ear drops, produced with or without preservatives for human and veterinary medicinal products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synerlab
Bioqual
HQ: United States
Website
- Description: Provider of AAALAC-accredited pre-clinical research and model development services, offering in vivo studies in small and large animal models, in vitro services (sample processing, virus stock generation, and assays including virus neutralization, hemagglutination inhibition, and quantitative PCR), vaccine evaluation (therapeutics and microbicides), drug therapy testing, and consulting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioqual company profile →
DynaKin
HQ: Spain
Website
- Description: Provider of contract research services featuring a GLP biolab, model-based drug development, GCP clinical trial design and execution, and product-oriented R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DynaKin company profile →
Gelpell
HQ: Switzerland
Website
- Description: Provider of manufacturing for food supplements and nutrients, offering soft gelatin capsules for oily and semi-solid preparations; Gelpell® beads for slow, even release and improved bioavailability; hard capsules with powders or Gelpell® beads; plant-based pea-starch soft capsules; blister packaging compliant with pharmaceutical standards; and bulk product supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gelpell company profile →
Sanner
HQ: Germany
Website
- Description: Provider of primary plastic packaging systems for pharmaceuticals and dietary supplements, offering desiccant capsules (AdCap), canisters, packets (AdPack), plastic tubes with desiccant caps, desiccant closures with glass bottles, and closures for aluminum tubes. Solutions deliver moisture and odor absorption, protection against mechanical damage and unauthorized opening, compatibility with standard dosing systems; aluminum options are airtight, lightproof, and breakproof.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sanner company profile →
CSSi
HQ: United States
Website
- Description: Provider of patient recruitment and enrollment services for clinical trials, leveraging a comprehensive patient database, digital advertising, and the Research Study Rockstar software to target qualified participants near study sites. Offers site support via Local Enrollment Specialists to optimize screening and enrollment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CSSi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synerlab
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synerlab
2.2 - Growth funds investing in similar companies to Synerlab
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synerlab
4.2 - Public trading comparable groups for Synerlab
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →